This is probably the best news we had regarding Covid-19 – a viable vaccine where clinical trials on humans commence next week.
Twenty-three healthy individuals will embark on this clinical trial next week. The vaccine which is based on the use of antibodies is developed by biotech company Tychan. There’s been debates about the pros & cons of using monoclonal antibodies for vaccines. Check out these articles below….